Anticancer composition inducing cell senescence and cell death
AssigneeOsteoneurogen Inc.
InventorsByung Soo YOUN, Moon Kee MEANG, Saes Byeol KIM, Ik Hwan KIM, Han Soo KIM
Life of this patent
Estimating the term…
Loading patent…
AssigneeOsteoneurogen Inc.
InventorsByung Soo YOUN, Moon Kee MEANG, Saes Byeol KIM, Ik Hwan KIM, Han Soo KIM
Estimating the term…
The present invention relates to an anticancer composition containing as an active ingredient a compound inducing cell senescence and apoptosis. The compound of the present invention can discriminate cancer cells and normal cells and induce both cell senescence and apoptosis in a cancer cell-specific manner. Thus, the compound does not need the attachment of any cancer cell-specific targeting substance thereto, can minimize the frequent adverse effects caused by the attack of anticancer agents on normal cells, and exhibits a potent anticancer effect on the basis of the aforementioned dual action.
A method for inhibiting or treating or ameliorating tumor or cancer disease in a subject in need thereof, comprising:
9-24. (canceled)
Dependencies are inferred from the claim text.